These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12958450)

  • 1. Live viral vectors: Semliki Forest virus.
    Karlsson GB; Liljeström P
    Methods Mol Med; 2003; 87():69-82. PubMed ID: 12958450
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of mammalian membrane proteins in mammalian cells using Semliki Forest virus vectors.
    Lundstrom K
    Methods Mol Biol; 2010; 601():149-63. PubMed ID: 20099145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of recombinant alphaviral vectors.
    Lundstrom K
    Cold Spring Harb Protoc; 2012 Jul; 2012(7):825-31. PubMed ID: 22753600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of DNA and RNA based on bifunctional replicon vector derived from Semliki Forest virus].
    Yu YZ; Sun ZW; Yu WY
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):713-8. PubMed ID: 16285510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.
    Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C
    Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of proteins using Semliki Forest virus vectors.
    Liljeström P; Garoff H
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.20. PubMed ID: 18265128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and prophylactic applications of alphavirus vectors.
    Atkins GJ; Fleeton MN; Sheahan BJ
    Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of specific human primary immune responses to a Semliki Forest virus-based tumor vaccine in a Trimera mouse model.
    Ni B; Gao W; Zhu B; Lin Z; Jia Z; Zhou W; Zhao J; Wang L; Wu Y
    Cancer Immunol Immunother; 2005 May; 54(5):489-98. PubMed ID: 15750833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportionate synthesis of Semiliki Forest virus 42S and 26S RNAs in polyamine-depleted baby hamster kidney cells.
    Tuomi K
    Med Biol; 1983; 61(4):199-202. PubMed ID: 6656320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
    Rautsi O; Lehmusvaara S; Salonen T; Häkkinen K; Sillanpää M; Hakkarainen T; Heikkinen S; Vähäkangas E; Ylä-Herttuala S; Hinkkanen A; Julkunen I; Wahlfors J; Pellinen R
    J Gene Med; 2007 Feb; 9(2):122-35. PubMed ID: 17191255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.
    Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ
    Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
    Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
    Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of attenuated Salmonella strains that express heterologous antigens.
    Bowe F; Pickard DJ; Anderson RJ; Londoño-Arcila P; Dougan G
    Methods Mol Med; 2003; 87():83-100. PubMed ID: 12958451
    [No Abstract]   [Full Text] [Related]  

  • 17. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
    Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and delivery of heterologous antigens using lactic acid bacteria.
    Reuter MA; Hanniffy S; Wells JM
    Methods Mol Med; 2003; 87():101-14. PubMed ID: 12958452
    [No Abstract]   [Full Text] [Related]  

  • 19. Semliki Forest virus vectors for gene transfer.
    Wahlfors J; Morgan RA
    Methods Mol Med; 2003; 76():493-502. PubMed ID: 12526181
    [No Abstract]   [Full Text] [Related]  

  • 20. Live viral vectors: construction of a replication-deficient recombinant adenovirus.
    Fooks AR
    Methods Mol Med; 2003; 87():37-50. PubMed ID: 12958448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.